If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,364.00    -54.00 (-2.23%)
Bid:
2,362.00
Ask:
2,364.00
Spread: 2.00 (0.085%)
Market Cap: £6.14b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Director/PDMR Shareholding

15 Mar 2010 15:17

RNS Number : 5978I
Weir Group PLC
15 March 2010
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING

MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

Β 

1.

Name of the issuer

Β 

THE WEIR GROUP PLC

2.

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.2R;

(ii) a disclosure made in accordance with LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act 2006.

Β 

(i)

Β 

3.

Name of person discharging managerial responsibilities/director

Β 

(1) ALAN MITCHELSON

(2) KEITH COCHRANE

(3) PHIL CLIFTON

Β 

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

Β 

NO

Β 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

Β 

3 ABOVE

Β 

Β 

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES OF 12.5P EACH

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

(1) ALAN MITCHELSON 205,691

(2) KEITH COCHRANE 83,954

(3) PHIL CLIFTON 69,388

Β 

8.

State the nature of the transaction

Β 

SALE OF SHARES TO SATISFY TAX COSTS FOLLOWING ON THE EXERCISE OF AN AWARD UNDER THE GROUP LONG TERM INCENTIVE PLAN DATED 29 JUNE 2007.

Β 

9.

Number of shares, debentures or financial instruments relating to shares acquired

Β 

N/A

Β 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

N/A

Β 

11.

Number of shares, debentures or financial instruments relating to shares disposed

Β 

(1) ALAN MITCHELSON 25,392

(2) KEITH COCHRANE 17,432

(3) PHIL CLIFTON 11,411

Β 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

N/A

Β 

13.

Price per share or value of transaction

Β 

922.8118p

Β 

14.

Date and place of transaction

Β 

12 MARCH 2010, LONDON

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

(1) ALAN MITCHELSON 180,299

(2) KEITH COCHRANE 66,522

(3) PHIL CLIFTON 57,977

Β 

16.

Date issuer informed of transaction

Β 

12 MARCH 2010

Β 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

Β 

17.

Date of grant

18.

Period during which or date on which it can be exercised

Β 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

Β 

21.

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22.

Total number of shares or debentures over which options held following notification

Β 

23.

Any additional information

24

Name of contact and telephone number for queries

Β 

FRANCES MCCAW

0141 308 3737

Β 

Β 

Β 

Name and signature of duly authorised officer of issuer responsible for making notification

Β 

………………FRANCES MCCAW………………………………………………

Β 

Date of notification ……………15 March 2010…………...……………………..

Β 

Β 

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4.

Β 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

Β 

(2) An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

Β 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

Β 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSJAMATMBBBBFM
Date   Source Headline
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding
8th Jun 20237:00 amRNSPricing of Sustainability-Linked Notes
7th Jun 202311:35 amRNSDirector/PDMR Shareholding
7th Jun 20239:20 amRNSStabilisation Notice
5th Jun 20238:25 amRNSWeir's commitment recognised in CCLA benchmark
1st Jun 20233:34 pmRNSTotal Voting Rights
25th May 20237:30 amRNSDirector Declaration
12th May 20234:42 pmRNSDirector PDMR shareholding
12th May 20238:19 amRNSDirector/PDMR Shareholding
3rd May 202312:55 pmRNSDirector/PDMR Shareholding
3rd May 202312:51 pmRNSTotal Voting Rights
28th Apr 20232:06 pmRNSBoard Committee Change and EE NED Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.